These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 1493054)

  • 1. Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection.
    Lorès P; Boucher V; Mackay C; Pla M; Von Boehmer H; Jami J; Barré-Sinoussi F; Weill JC
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2063-71. PubMed ID: 1493054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection.
    Liberatore RA; Mastrocola EJ; Cassella E; Schmidt F; Willen JR; Voronin D; Zang TM; Hatziioannou T; Bieniasz PD
    Elife; 2019 Oct; 8():. PubMed ID: 31644426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene inoculation generates immune responses against human immunodeficiency virus type 1.
    Wang B; Ugen KE; Srikantan V; Agadjanyan MG; Dang K; Refaeli Y; Sato AI; Boyer J; Williams WV; Weiner DB
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4156-60. PubMed ID: 8483929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.
    Redfield RR; Birx DL; Ketter N; Tramont E; Polonis V; Davis C; Brundage JF; Smith G; Johnson S; Fowler A
    N Engl J Med; 1991 Jun; 324(24):1677-84. PubMed ID: 1674589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.
    Stanhope PE; Clements ML; Siliciano RF
    J Infect Dis; 1993 Jul; 168(1):92-100. PubMed ID: 8099941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK; Katzenstein D; Moses LE; Merigan TC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy.
    Lin X; Dashti A; Schinazi RF; Tang J
    FASEB J; 1993 Aug; 7(11):1070-80. PubMed ID: 8370478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD4 antibodies generated in response to HIV-1 rgp160 immunization of HIV-1-infected chimpanzees.
    Keiser P; Fernie B; Tacket C; Wecksler W; Keay S
    AIDS; 1993 Jan; 7(1):136-8. PubMed ID: 8442909
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
    Keay S; Tacket CO; Murphy JR; Handwerger BS
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of human immunodeficiency virus-specific T cell responses in rhesus monkeys by synthetic peptides from gp160.
    Nehete PN; Satterfield WC; Matherne CM; Arlinghaus RB; Sastry KJ
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):235-40. PubMed ID: 8471313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice.
    Shirai A; Klinman DM
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):979-83. PubMed ID: 8280480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 gp120/160 expressing transfected cell clones to evaluate the antibody-dependent cellular cytotoxicity (ADCC) during the course of HIV-1 infection.
    Merzouki A; Patel P; Cassol S; O'Shaughnessy M; Gill J; Arella M
    J Virol Methods; 1994 Jun; 48(1):9-21. PubMed ID: 7962264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope.
    Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Schmitt D; Pasquali JL; Olivier R
    J Dermatol; 1991 Jul; 18(7):377-92. PubMed ID: 1724250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.